Скачать или смотреть When Stocks Go Down, Should Investors Panic? NO!

Halloween only comes once a year, but for investors, the entire month of October was frightful. The S&P 500 index tumbled nearly 10% from the end of September to its low on October 29 and the returns in biotech were even more dreadful, with the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) losing about 15% of its value at one point. Drops like that can test the nerves of even the most level-headed investor, so in this episode of The Motley Fool's Industry Focus: Healthcare, host Shannon Jones is joined by Motley Fool contributor Todd Campbell to put these grizzly events in perspective and offer up insight into lessons investors can learn from some of this year's scariest biotech stocks.

In this episode, Jones and Campbell discuss:

Why 10% corrections shouldn't cause you to panic.
What Geron Corporation's (NASDAQ: GERN) terrifying tumble teaches us about binary risk
How Synergy Pharmaceuticals (NASDAQ: SGYP) shocking disclosure is a reminder to look behind the curtain at a company's financials
Why Incyte Corporation's (NASDAQ: INCY) horrific trial results were disheartening
Tips to surviving the next market tumble
------------------------------------------------------------------------
Subscribe to The Motley Fool's YouTube Channel:
   / themotleyfool  
Or, follow our Google+ page:
https://plus.google.com/+MotleyFool/p...

Inside The Motley Fool: Check out our Culture Blog!
http://culture.fool.com
Join our Facebook community:
  / themotleyfool  
Follow The Motley Fool on Twitter:
  / themotleyfool